APA (7th ed.) Citation

Simanenkova, A. V., Minasian, S. M., Karonova, T. L., Vlasov, T. D., Timkina, N. V., Khalzova, А. K., . . . Galagudza, M. M. (2021). Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus. Endocrinology Research Centre.

Chicago Style (17th ed.) Citation

Simanenkova, A. V., et al. Comparative Evaluation of Empagliflozin, Canagliflozin and Sitagliptin Cardioprotective Properties in Rats with Experimental Type 2 Diabetes Mellitus. Endocrinology Research Centre, 2021.

MLA (9th ed.) Citation

Simanenkova, A. V., et al. Comparative Evaluation of Empagliflozin, Canagliflozin and Sitagliptin Cardioprotective Properties in Rats with Experimental Type 2 Diabetes Mellitus. Endocrinology Research Centre, 2021.